Merdad Parsey - Dec 10, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Edward S. Son by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Dec 10, 2024
Transactions value $
-$163,534
Form type
4
Date filed
12/11/2024, 07:24 PM
Previous filing
Nov 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.82K +4.73% 84.6K Dec 10, 2024 Direct F1
transaction GILD Common Stock Tax liability -$164K -1.77K -2.09% $92.34 82.9K Dec 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.82K -9.42% 36.8K Dec 10, 2024 Common Stock 3.82K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.